Health Care · Services-Health Services · Nasdaq · CIK 1759655 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $24.12Day −2.86%Mkt cap $3.0BP/E (FY) 134.0×1Y +23.8%Off 52W high −16.3%Vol (1Y) 34.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 942 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest2.9% of sh out |
| Days to cover3.3d |
| 13F net flow (QoQ)+2.40% |
| Top-10 13F concentration64.7% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)134.0× |
| Sales (TTM)$2.25B |
| Earnings (TTM)$21.8M |
| ROE3.3% |
| Net margin1.1% |
| ROIC9.2% |
| Sales growth 3Y16.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+1.7% |
| 1Y+23.8% |
| 3Y−13.6% |
| Since incept. (ann.)−8.7% |
Total return through 2026-07-29 · series begins 2022-10-18. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)34.0% |
| Ann. volatility (3Y)39.5% |
| Sharpe (1Y)0.78 |
| Sharpe (3Y)0.10 |
| Max drawdown (1Y)−24.2% |
| Max drawdown (3Y)−42.4% |
| Beta (3Y vs SPY)1.03 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 19.1M | $392M | 15.41% | +0.5% |
| FMR LLC | 13.0M | $268M | 10.55% | +8.3% |
| Durable Capital Partners LP | 12.1M | $249M | 9.77% | +0.0% |
| Van Berkom & Associates Inc. | 8.1M | $167M | 6.55% | +110.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.3M | $129M | 5.08% | new |
| Rubicon Founders LLC | 5.9M | $122M | 4.81% | +3.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.0M | $103M | 4.05% | new |
| STATE STREET CORP | 4.5M | $92M | 3.63% | +5.1% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 101.0% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 3,201,655 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | $0.02 | −33.3% | $603.8M | +25.8% |
| 2025-12-31 | 2026-02-26 | — | — | $541.2M | +17.4% |
| 2025-09-30 | 2025-11-06 | $0.05 | +66.7% | $580.4M | +32.5% |
| 2025-06-30 | 2025-08-07 | $0.02 | −33.3% | $521.2M | +23.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
FFSPatient Care 64% · Capitated Revenue 15% · Shared Savings 11% · FFSAdministrative Services 6% · Care Management Fee PMPM 3%
product & service · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
